Arrevus is a clinical-stage biotechnology company based in the Research Triangle Park (North Carolina). Arrevus was established in 2017 by Dr. Carl Kraus, an NIH-trained infectious disease physician and former FDA Medical Officer, with the mission to identify promising neglected compounds and develop them for orphan or serious indications. The company has a strong pipeline targeting orphan indications in cancer and infectious diseases.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):